10 May 2018 1 Min Read
Finance chief to leave GSK after two transformational deals
The departure provides a further opportunity for GlaxoSmithKline CEO Emma Walmsley to stamp her imprint on Britain’s biggest drug maker
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In